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Polyomavirus productively infects mouse cells, transforms rat fibroblasts in culture, and induces a broad spectrum of
tumors when inoculated into newborn mice. The expression of large, middle, and small T antigen are necessary for virus
growth and oncogenic transformation. We have generated a small deletion in a region common to both large and middle T
antigen that encodes three consecutive prolines. In this report we characterize this mutant virus in terms of its ability to
replicate in mouse cells, transform rat fibroblasts, and induce tumors in the mouse. We find that the virus immortalizes
primary cells and that viral DNA replication is not impaired, indicating that these functions of large T antigen are not altered.
However, the ability of the virus to transform rat fibroblasts is defective. The mutant virus makes fewer foci and the foci are
weaker in appearance. The mutant middle T still associates with PI 3-kinase and shc, suggesting that the overall structure
of the protein has not been disrupted. When inoculated into newborn C3H mice, the mutant virus induces fewer overall
tumors with a longer latency than wild-type virus. These results indicate that this proline-rich domain in middle T antigen is
important for oncogenesis in a wide variety of tissues and cell types. © 1998 Academic Press
INTRODUCTION
Polyomavirus encodes three early genes, large, mid-
dle, and small T antigen, that are necessary for both lytic
infection and neoplastic transformation, and three struc-
tural genes, which make up the viral capsid (Tooze,
1980). The T antigens perform their functions in lytic
infection and transformation by associating with and
regulating cellular proteins normally involved in signal
transduction and growth control. Much of our under-
standing of the function of the T antigens is due to
genetic studies with mutant viruses. Originally, using
temperature-sensitive mutants of large T antigen, tsa
mutants, it was shown that large T antigen was neces-
sary for the stimulation of host DNA synthesis (Fried,
1970; Schlegel and Benjamin, 1978) and initiation of viral
DNA replication (Fried, 1970; Franke and Eckhart, 1973).
Studies with tsa mutants showed that the only role of
large T antigen in transformation was in the initiation of
transformation (Fried, 1970; Eckhart, 1977) by integrating
the viral genome into host DNA. More recent studies
have shown that large T antigen associates with the
retinoblastoma tumor suppressor gene product, and this
association is necessary for the virus to immortalize
primary cells (Dyson et al. 1990; Larose et al. 1991;
Freund et al. 1992a; Holman et al. 1994; Mudrak et al.
1994). It has also been shown that large T antigen asso-
ciates with the heat shock 70 protein (Sheng et al. 1997).
Studies on another mutant, hrT, revealed that an over-
lapping region of middle and small T antigen is neces-
sary for lytic infection and transformation of established
cells (Carmichael and Benjamin, 1980; Benjamin, 1982).
Biochemical and genetic studies have shown that middle
T must associate with members of the src family of
tyrosine kinases to transform cells (Benjamin, 1982; Car-
michael et al. 1982; Bolen et al. 1984; Coutneidge and
Smith, 1983; Kornbluth et al. 1987; Markland and Smith,
1987). As a result of these associations, middle T antigen
is phosphorylated on several tyrosine residues (Schaff-
hausen and Benjamin, 1979), which act as binding sites
for phosphatidylinositol 3-kinase (Whitman et al. 1985;
Kaplan et al. 1986; Talmage et al. 1989; Auger et al. 1992),
shc (Campbell et al. 1994; Dilworth et al. 1994), and
phospholipase C-g (Su et al. 1995). Site-directed mu-
tagenesis of specific tyrosines has shown that the asso-
ciation of both PI 3-kinase and shc with middle T antigen
is necessary for full transformation (Carmichael et al.
1984; Whitman et al. 1985; Kaplan et al. 1986; Markland et
al. 1986; Talmage et al. 1989; Druker et al. 1990; Dahl et
al. 1996; Yi et al. 1997). In addition, both middle and small
T antigen have been shown to associate with protein
phosphatase 2A (Pallas et al. 1990; Walter et al. 1990),
while middle T antigen also associates with 14–3-3 (Pal-
las et al. 1994).
Polyomavirus was so named because of its ability to
induce neoplasms in a wide variety of cell types (Eddy et
al. 1958). Under appropriate experimental conditions,
high-tumor strains induce a broad array of tumors of both
epithelial and mesenchymal origin (Dawe et al. 1987;
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Gross, 1983; Eddy, 1969). The wild-type strain, PTA, in-
duces a high frequency of salivary gland, mammary
gland, thymic, kidney, and hair follicle tumors when in-
oculated into newborn C3H/BiDa mice (Dawe et al. 1987;
Freund et al. 1988). To study the roll of the T antigens and
their interactions with other cellular proteins in the in-
duction of different tumor types, mutations have been
introduced into the PTA virus background, which con-
tains all known genetic determinants necessary for tu-
mor induction. The tumor-inducing properties of several
mutants have been reported. Mutant viruses that encode
an altered large T antigen that fails to bind the RB
proteins induced multiple tumor types in mice, suggest-
ing that the LT-RB interaction is not essential for the
induction of these tumors in this system (Freund et al.
1992a). Studies on a virus containing a mutation in mid-
dle T antigen that changes the tyrosine at 315 to phenyl-
alanine, creating a middle T that cannot bind PI 3-kinase,
induced an overall lower frequency of tumors that wild-
type virus (Talmage et al. 1989; Freund et al. 1992b). In
addition, some tumor types were affected more dramat-
ically than others; the mutant virus induced very few
salivary and kidney tumors and the thymic and mammary
gland tumors were morphologically different from those
induced by PTA (Talmage et al. 1989; Freund et al. 1992b).
In another study, a mutant virus containing a serine in
place of the tyrosine at position 250 in middle T, disrupt-
ing the association of middle T antigen with shc, induced
tumors in 100% of the inoculated mice but the spectrum
of tumors and their morphology was altered compared
with wild-type virus (Bronson et al. 1997; Yi et al. 1997).
These studies show that by disrupting cellular protein–
viral protein interactions we can assess the role of dif-
ferent signaling pathways in tumor formation.
In this study we report the biological properties of a
mutant virus that contains a deletion of nine nucleotides
in the middle T/large T region. This nine nucleotide
deletion deletes three consecutive proline residues in
both proteins. This proline-rich domain is of interest for
several reasons. Two previously characterized viruses,
dl23 and dl1015, which contain large deletions near this
region, have been shown to have defects in both large T
and middle T functions (Griffin et al. 1980; Magnusson et
al. 1981; Smolar and Griffin, 1981). Furthermore, SH3
domains found in some cytoskeletal and signaling pro-
teins bind proline-rich domains (Ren et al. 1993). The
region surrounding these three prolines in middle T an-
tigen is similar to consensus SH3 binding sites (Ren et
al. 1993; Yu et al. 1994). Here we show that the mutant
virus, PTA-Dpro, is defective in transformation and tumor
inducing ability, yet grows to high titer in culture and
grows well in the kidneys of infected mice. The mutant
large T supports viral DNA replication and immortalizes
primary cells. The mutant middle T antigen still associ-
ates with PI 3-kinase and shc. The data indicate that the
deletion affects middle T antigen function and suggest
that middle T antigen regulates the activity of unidenti-
fied cellular proteins through this proline-rich domain.
RESULTS
Description of mutant virus
Upon inspection of the amino acid sequence of the
early region of polyomavirus, we observed that the over-
lapping reading frames of both middle and large T anti-
gen contained a region that had a high proportion of
prolines including three adjacent ones. The middle T
sequence, I P P P I I P R, appeared as a possible
potential SH3 binding domain (Ren et al. 1993; Yu et al.
1994). In addition, this region was adjacent to a previ-
ously characterized mutant virus, dl1015, which had been
shown to dramatically alter both middle T and large T
function (Magnusson et al. 1981). To evaluate the role of
these prolines in middle and large T antigen, we con-
structed a virus that contained a deletion of nine nucle-
otides and thus would express a mutant large and mid-
dle T antigen that were missing three adjacent prolines.
We constructed the deletion using site-directed mu-
tagenesis, transfected the viral genome into NIH3T3
cells, and generated a stock of virus on BMK cells that
we designated PTA-Dpro as described in Materials and
Methods. The presence of the deletion in the virus was
confirmed by sequence analysis. A comparison of the
wild-type and mutant large T and middle T sequence is
shown in Fig. 1.
To characterize the mutant virus, we compared the
expression of viral proteins with the wild-type, parental
strain, PTA. Approximately equal titer of PTA-Dpro and
FIG. 1. Illustration of the deletion of three consecutive prolines in the
overlapping reading frame of large and middle T antigen. The nucleo-
tide sequence from the wild-type and mutant (mut-Dpro) polyomavirus
genome (nucleotide 1225 to 1263) and the encoded amino acids in
large (LT) and middle T (MT) antigen are shown below in a schematic
representation of the early region of the viral genome. Deletion of these
three prolines removes amino acids 336 to 338 in middle T and amino
acids 228 to 230 in large T antigen.
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wild-type virus as well as 3- and 10-fold dilutions of
wild-type virus was used to infect NIH3T3 cells. Thirty
hours postinfection cell lysates were made and viral
gene products were visualized by Western blotting with
one antibody that recognizes large, middle, and small T
antigen (Fig. 2A), and another that recognizes the major
coat protein, VP1 (Fig. 2B). The results indicate that
expression of the early and late viral gene products is not
impaired by the mutation, although the titer of PTA-Dpro
may be slightly less than PTA. The migration of middle T
antigen of PTA-Dpro is detectably faster than that of PTA
while the size difference between the two large T anti-
gens is not apparent on this percentage polyacrylamide
gel. The results suggest that the deletion does not affect
the large T or middle T functions involved in viral protein
synthesis or productive infection of established cells.
Mutant virus replicates to same extent
as wild-type virus
Studies with large T antigen have shown that this viral
protein is necessary for viral DNA replication (Francke
and Eckhart, 1973; Gross, 1983). To determine whether
this deletion in large T antigen altered the level or kinet-
ics of viral DNA replication, we compared the accumu-
lation of viral DNA from cells infected by wild-type and
mutant virus. Cellular DNA from NIH3T3 cells infected
with PTA-Dpro, PTA, and a threefold dilution of PTA, was
isolated at various times post infection. Viral DNA was
quantified by Southern blotting with a viral DNA probe.
Figure 3 shows the level of viral DNA 0, 4, 16, 24, and
32 h p.i. Viral DNA from cells infected with PTA-Dpro
accumulates to levels between those of undiluted and
threefold dilution of PTA. This is similar to the levels of T
antigen synthesis shown in Fig. 2 and probably reflects a
slight titer difference between the stock of PTA-Dpro and
PTA. The results indicate that the deletion in large T
antigen does not alter the replication function of the
protein.
Mutant virus immortalizes primary rat embryo
fibroblasts
Previous studies have shown that the ability of large T
to immortalize cells is due to the interaction of large T
antigen with the retinoblastoma tumor suppressor gene
product, pRb (Dyson et al. 1990; Larose et al. 1991;
Freund et al. 1992a). Although the mutation in large T
antigen in the virus, PTA-Dpro, is downstream from the
amino acid domain involved in the LT-pRb interaction, we
tested the ability of the virus to immortalize primary cells.
Secondary rat embryo fibroblasts were infected with
equal titers of the viruses, PTA, PTA-Dpro, and PTA1387T.
PTA1387T was used as a positive control in this experi-
ment because it encodes a wild-type large T antigen and
FIG. 3. Levels and kinetics of viral DNA replication in mutant and
wild-type virus are similar. DNA was isolated from cells infected with
PTA-Dpro, PTA, and a1/3 dilution of PTA at 0, 4, 16, 24, and 32 h p.i. and
amount of viral DNA determined by Southern blot analysis.
FIG. 2. Mutant and wild-type virus express early and late gene
products to similar levels. Equal titers of PTA-Dpro and PTA, as well as
3- and 10-fold dilutions of PTA- and mock-infected cell lysates were
used to infect NIH 3T3 cells. After 30 h the cells were lysed, and 50 mg
of total protein was analyzed by immunoblotting. (A) Probed with F4, a
monoclonal antibody which recognizes the N-terminal region of large
(LT), middle (MT) and small T antigen (ST). (B) Probed with an antibody
that recognizes the major coat protein, VP1. Lane 1, mock-infected cells;
lane 2, cells infected with PTA; lane 3, cells infected with 1/3 dilution of
PTA; lane 4, cells infected with 1/10 dilution of PTA; lane 5, cells
infected with PTA-Dpro.
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a mutant nontransforming middle T antigen. Virus- and
mock-infected cells were plated at 103, 104, and 105 cells
per 100-mm plate and subcultured at 104 cells per plate
whenever the cells reached confluence. After approxi-
mately 15 passages, growth of the mock-infected cells
slowed and the cells died, while established cells
emerged from the fibroblasts infected with all the vi-
ruses. The established cell lines grew vigorously with
generation times of approximately 24 h and had a high
cloning efficiency (.20%). These results indicate that the
mutant large T antigen in PTA-Dpro is capable of immor-
talizing primary cells and that the mutation does not alter
this large T antigen function.
Mutant virus is transformation-defective
To evaluate the ability of the mutant virus to transform
cells, we compared the number and appearance of foci
induced by both wild-type and mutant virus. Table 1
shows the number of foci that were induced on the rat
fibroblast cells line, F111, by PTA-Dpro, PTA, and 3- and
10-fold dilutions of PTA. PTA-Dpro induced 10- to 40-fold
fewer foci than an equivalent titer of PTA. The foci also
differed in appearance. The cells transformed by PTA-
Dpro were more adherent than those of wild type, did not
pile up on themselves, and were not as refractory as
those induced by wild type. The cells were discernible
from nontransformed F111 cells in that they were hexa-
gonal in shape and less elongated than nontransformed
cells (Fig. 4).
The reduction in the number of foci induced by the
mutant virus may be due to a defect in a large T antigen
function, viral DNA integration into host DNA. To test this
possibility, cloned viral DNA was transfected into F111
cells. Because integration of transfected DNA is not a
function of large T antigen, reduction in the number of
foci induced by mutant DNA compared with wild-type
DNA would indicate that this decrease is due to a defect
in middle T antigen. Cells were cotransfected with
cloned viral DNA from PTA, PTA-Dpro, PTA250YS, and
pSVneo. PTA250YS has previously been shown to be
defective in its ability to transform cells (Dahl et al. 1996;
Bronson et al. 1997; Yi et al. 1997). Half the transfected
cells were analyzed for focus formation and, as a trans-
fection control, the other half for G418 resistant colonies.
Both PTA-Dpro and PTA250YS transfected cells showed
a reduction in the number of foci compared with that of
PTA, although the number of G418 resistant colonies in
all three transfections was similar (Table 2). The appear-
ance of the foci in the cells transfected with PTA-Dpro
DNA was very similar to the appearance of those result-
ing from cells infected with PTA-Dpro virus.
The results from these experiments suggest that abil-
ity to transform cells in culture is, for the most part, the
result of the expression of middle T antigen. Thus, the
reduction in focus formation and the morphological dif-
ferences suggest that the deletion of these three prolines
FIG. 4. Mutant virus induces foci with altered morphology. Represen-
tative foci from F111 rat fibroblasts infected with wild-type (A), PTA-Dpro
(B), and mock (C) virus lysates are illustrated.
TABLE 1
Quantification of Foci Induced by Wild-Type
and Mutant Virus, PTA-Dpro
Virus Dilution No. of foci
PTA 10-fold 34
3-fold 88
— 356
PTA-Dpro — 8
Note. F111 cells were infected with equal titers of PTA-Dpro and PTA
or dilutions of PTA. Focus forming assay was performed as described
in Materials and Methods. Foci were counted after 14 days.
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in middle T antigen severely alters the ability of that
protein to transform cells in culture.
Mutant middle T associates with shc and PI 3-kinase
Wild-type middle T antigen is phosphorylated on sev-
eral tyrosine residues that act as binding sites for cellu-
lar proteins, including phosphatidylinositol 3-kinase, shc,
and phospholipase C-g (Kaplan et al. 1986; Talmage et al.
1989; Campbell et al. 1994; Dilworth et al. 1994; Su et al.
1995). Previous studies have shown that disruption of the
association of middle T with PI 3-kinase and shc has a
dramatic effect on the virus’s ability to transform cells
(Carmichael et al. 1984; Whitman et al. 1985; Kaplan et al.
1986; Markland et al. 1986; Dahl et al. 1996; Yi et al. 1997).
To determine whether the deletion of these prolines
affects the binding of middle T to these cellular proteins,
we generated several independent cell lines by trans-
fecting cloned viral DNA into the established rat fibro-
blast line, F111. Cloned cell lines, which express approx-
imately equal amounts of wild-type middle T, mt-Dpro,
and mt-1387T were expanded and used for these exper-
iments (Fig. 5A). Extracts from these cells were immuno-
precipitated with antibodies to T antigens and the im-
mune complexes analyzed by western blotting. Figure 5B
shows an immunoblot probed with anti-PI 3 kinase anti-
bodies, and Fig. 5C shows a blot probed with anti-shc
antibodies. These results show that both the wild-type
middle T and mt-Dpro associate with the 85-kDa regula-
tory subunit of PI 3-kinase and shc, while the truncated
middle T, mt-1387T, did not. This suggests that the 3
proline mutation within middle T does not disrupt the
overall structure of the protein and that the mutant mid-
dle T still associates with pp60c-src, is phosphorylated on
tyrosine 250 and 315, and still associates, at least to
some extent, with these cellular proteins.
Mutant virus is partially defective for tumor induction
To determine the tumor inducing capabilities of PTA-
Dpro, we inoculated approximately 20 newborn C3H
mice with the mutant virus and compared the percentage
of mice with tumors and the tumor types that were
induced by PTA-Dpro to the percentage and types in-
duced by PTA. Table 3 shows the tumor profile of the two
viruses. Only 67% of the PTA-Dpro inoculated mice de-
veloped tumors compared with 100% of those inoculated
with PTA. Of the 21 PTA-Dpro inoculated mice, 11 were
necropsied at 6 months p.i., the end point of the exper-
iment, 7 had no apparent lesions and the other 4 had
small tumors. The average age of necropsy for PTA-
Dpro-inoculated mice was 158 days, while the average
age for wild-type inoculated mice was significantly
shorter, 76 days. Comparison of the tumor types induced
by the two viruses also shows considerable differences.
Wild-type virus induced a high frequency of tumors of the
mammary gland, salivary gland, thymus, hair follicle, and
kidney, while the mutant virus only induced tumors of the
mammary gland and hair follicles.
A more detailed analysis of the mammary tumors in-
duced by the two viruses further exemplifies the differ-
ences between the viruses. In the group of mice inocu-
lated with PTA-Dpro there were 13 female mice, 8 of
which had mammary tumors, and 8 males, 1 of which
had a single mammary tumor. In the wild-type inoculated
group 100% of the females and 60% of the males had
mammary tumors. In PTA inoculated mice, there was an
average of 5.6 fat pads with mammary tumors per female
mouse and 1.5 mammary tumors in male mice, while in
the PTA-Dpro group 6 females had no tumors at all, and
the 7 with at least one mammary tumor had an average
of 1.6 tumors. Histological examination of the mammary
tumors from the mutant inoculated group revealed that
most of the tumors were adenocarcinomas of the
comedo type and histologically were very similar to
those induced by wild-type virus (Dunn, 1959; Freund et
al. 1992b; Yi et al. 1997).
Comparison of the tumor profiles indicates that PTA-
Dpro is partially defective in its ability to induce tumors.
The mutant virus produces an overall reduction in tumor
induction as illustrated by the lower frequency of tumors
in general, and specifically fewer mammary tumors, as
well as having a longer average time to necropsy com-
pared with wild type. In addition, certain tumor types
were not induced by PTA-Dpro at all, including those of
the kidney, thymus, and salivary gland. Interestingly, his-
tological examination of apparently normal salivary
glands, kidneys, and thymii from PTA-Dpro inoculated
mice showed no occult kidney lesions and less than 10%
of the mice contained salivary or thymic lesions.
Mutant virus replicates efficiently in the early stages
of infection
Previous studies have shown that tumor induction is
dependent on an initial disseminated viral infection in the
mouse (Dubensky et al. 1991). Kidneys are one of the
major sites of viral amplification during the initial stages
TABLE 2
Number of Foci and G418 Resistant Colonies Induced by Transfection
of Cloned DNA from PTA, PTA-Dpro, and PTA250YS
DNA No. of foci No. of G418R colonies
PTA/pSvneo 24 30
PTA-Dpro/pSVneo 3 25
PTA250YS/pSVneo 1 22
pSVneo 0 21
Note. F111 cells were cotransfected with 4 mg of either PTA, PTA-Dpro,
or PTA250YS and 1 mg of pSVneo DNA. Foci and G418 resistant colonies
were assayed after 21 days as described in Materials and Methods.
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of infection (Rowe et al. 1959; Dubensky and Villarreal,
1984; Dubensky et al. 1991). Thus, we examined the
ability of PTA-Dpro to grow in the kidney of the mouse
after 12 and 25 days of infection. Mice were inoculated
with either PTA or PTA-Dpro at birth and sacrificed at 12
and 25 days p.i. The levels of viral DNA were determined
by Southern blotting of total DNA isolated from infected
kidneys and the degree of lytic infection measured by
immunocytochemistry. Figure 6 shows the level of viral
DNA in two mice infected with each virus at both 12 and
25 days p.i. Although the level of viral DNA is slightly
lower in the kidneys of mutant-infected mice at each time
point, it is unlikely that this difference can account of the
dramatic differences observed in the tumor profiles of
the two viruses. Immunoperoxidase staining for VP1 on
sections of kidney from 12- and 25-day-old mice infected
with PTA and PTA-Dpro show that the level of virus
growth in the kidney of mice infected with mutant virus is
similar to that of wild-type infected kidneys (not shown).
Together the two techniques suggest that growth of
PTA-Dpro is at most slightly reduced compared with
wild-type virus in the early stages of viral infectious and
dissemination. It is unlikely that this small difference can
account for the dramatic differences observed in the
tumor profiles of the two viruses.
PTA-Dpro induced tumors retain the 3 proline
deletion
Two different approaches were used to determine that
the low frequency of tumors induced by the mutant virus
were due to the original mutation and not due to rever-
tants or to a low level of contamination by wild-type virus.
We reisolated virus from two mammary tumors induced
by PTA-Dpro and amplified and subsequently sequenced
the nucleotides surrounding the mutated site. In both
cases the nucleotide sequence was identical to that of
the original mutation, containing a deletion of the nine
nucleotides. In addition we examined expression of T
antigens in protein extracts from two other mammary
tumors induced by the mutant virus by western blot.
Figure 7 shows that middle T antigen expressed in PTA-
Dpro induced tumors migrates slightly faster than that
from wild-type induced tumors. This mobility difference is
similar to that observed in Fig. 2, where extracts from
NIH3T3 cells acutely infected with mutant and wild-type
virus were examined. Interestingly, the tumors induced
by the mutant virus also contain a truncated large T
antigen, which is commonly observed in mammary tu-
mors induced by wild-type polyomavirus (Talmage et al.
1992). These data clearly indicate that the partially de-
fective tumor inducing capabilities of the mutant virus
were the result of the virus containing the deletion.
DISCUSSION
In this study we characterize a mutant polyomavirus
containing a 9-bp deletion in the overlapping large and
FIG. 5. Mutant middle T antigen associates with PI 3-kinase and shc.
(A) Immunoblot of middle T antigen from 50 mg of total protein from cell
lines expressing wild-type and mutant middle T antigen. Immunoblots
showing anti-middle T antibody immune complexes made from 500 mg
of total protein from cell lines expressing wild-type and mutant middle
T antigen probed with an anti-PI 3-kinase antibody (B) and anti-shc
antibody (C). Lane 1, wild-type middle T; lanes 2 to 4, PTA-Dpro middle
T; lane 5, 1387T middle T; lane 6, pSVneo. The migration of immuno-
globulin G (IgG), middle T (MT), PI-3 kinase (PI 3K), and the shc isoform
(shc) are indicated.
TABLE 3
Tumor Profiles of Mutant Virus, PTA-Dpro, and Wild-Type Virus, PTA
Virus PTA PTA-Dpro
Fraction of mice with tumors 23/24 (96) 14/21 (67)
Mean age at necropsy, days 76 (63–89) 158 (101–186)
Number of mice with tumors
Mammary gland 16 (67) 8 (38)
Salivary gland 7 (29) 0
Thymus 23 (96) 0
Hair follicle 23 (96) 14 (67)
Kidney 20 (83) 0
Note. Newborn C3H/BiDa mice were inoculated intraperitoneally
with mutant virus, PTA-Dpro, or parental wild-type virus, PTA. Mice were
sacrificed when moribund or after 6 months. Numbers refer to macro-
scopic tumors of a given type detected at necropsy and were subse-
quently confirmed histologically. Numbers in parentheses are percents
except for mean age data, which are the range in days.
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middle T antigen region. This mutation results in a dele-
tion of three prolines in middle T antigen and in large T
antigen a 3 proline deletion as well as a tyrosine to
histidine change. We specifically targeted this region for
several reasons. (1) A previously characterized viruses,
dl1015, which contains a large deletion near this region,
has been shown to have defects in both large T and
middle T functions (Magnusson et al. 1981). (2) The
region surrounding these three prolines in middle T an-
tigen is similar to the consensus SH3 binding sites (Ren
et al. 1993; Yu et al. 1994). Phenotypically, we found this
mutant virus to be partially defective in transformation
and tumorigenesis. It induced fewer foci with a weaker
morphology than an equal titer of wild-type virus. It also
induced fewer overall tumors with a longer latency when
inoculated into newborn C3H mice compared with wild-
type. The mutant virus did not induced salivary, kidney or
thymic tumors and induced a reduced frequency of mam-
mary and hair follicle tumors.
Because the mutant virus has lesions in both large
and middle T antigen, we investigated functions attrib-
uted to both viral proteins. Studies have shown that large
T antigen is necessary for viral DNA replication, immor-
talization of primary cells, and integration of the viral
genome into host DNA, a step necessary for the initiation
of transformation (Francke and Eckhart, 1973; Tooze,
1980; Rassoulzadegan et al. 1983; Cowie et al. 1986). We
found that the mutant virus replicates its DNA with sim-
ilar kinetics and to the same extent as wild-type virus. We
also show that this mutant virus immortalizes 1° rat
embryo fibroblasts. In an attempt to determine whether
the decreased number of foci induced by the mutant
virus was due to the inability of the viral DNA to integrate
into the host DNA, we compared foci induced by trans-
fected DNA from both mutant and wild-type virus. We
found that even in this assay, the mutant induced a
reduced number of foci, and they had a weaker morphol-
ogy compared with wild type. In addition, we found that
the mutant virus grew efficiently in the kidneys of inoc-
ulated mice, and therefore this was unable to account for
the reduction in tumors induced in the mouse. We con-
clude from these studies that the alteration in large T
antigen does not interfere with the functions of large T
antigen necessary for viral growth and oncogenesis. We
cannot rule out the possibility that the lesion in large T
does affect certain tumor types. In particular, our previ-
ous studies have shown that even single amino acid
changes in large T antigen in regions with no known
function seem to alter the frequency of salivary and
thymic tumors (Freund et al. 1991). In addition, the dele-
tion in large T antigen may affect the initiation of tumor
induction, resulting in the overall reduction of tumors or
in the induction of a particular tumor type.
Based on the results of the experiments presented we
attribute the observed phenotype of this mutant virus, for
the most part, to the lesion in middle T antigen. One
possibility is that this deletion of three adjacent prolines
in middle T antigen disrupts the overall structure of the
protein. The oncogenic function of middle T antigen re-
quires the association of middle T with pp60c-src (Cout-
neidge and Smith, 1983). This interaction activates the
pp60c-src tyrosine kinase function (Bolen et al. 1984), and
middle T serves as a substrate for this enzymatic activity.
The phosphorylated tyrosines on middle T then act as
binding sites for several cellular signaling molecules
including shc and PI 3-kinase (Whitman et al. 1985;
Kaplan et al. 1986; Talmage et al. 1989; Dilworth et al.
1994; Dahl et al. 1996; Yi et al. 1997). We show that
the mutant middle T still associates with shc and PI
3-kinase, indicating that middle T still interacts with
pp60c-src, activating its tyrosine kinase activity and in
addition, the results suggest that the overall structural
integrity of middle T is not disrupted by the deletion.
Furthermore, the results suggest that middle T antigen
regulates the activity of unidentified cellular proteins
through this proline-rich domain.
Which cellular proteins associate with this domain are
not known. The fact that this region is proline-rich sug-
gests that it may interact with a SH3 domain (Ren et al.
1993; Yu et al. 1994). Sequence alignment of several SH3
binding motifs reveals that a PXXP motif is completely
conserved. Screening of peptide libraries suggests that
multiple prolines are conformational favorable and resi-
dues surrounding the PXXP motif confer specificity (Yu et
FIG. 6. Comparison of viral DNA replication of wild-type and mutant
virus in kidneys of infected mice. DNA was isolated from kidneys of 12-
or 25-day-old mice infected at birth with PTA or PTA-Dpro. Each lane
represents the DNA from the kidney of a single mouse. DNA was
electrophoretically separated, blotted to membrane, and probed with
cloned viral DNA.
426 YI AND FREUND
al. 1994). The middle T motif, I P P P I I P R, fits the SH3
binding consensus sequence but does not contain some
of the crucial residues found in the consensus sites
using the PI 3-kinase or src SH3 domains identified
using peptide library screening (Yu et al. 1994). It is
possible that middle T binds another SH3 domain found
in another intracellular signaling protein.
Another clue as to the role of this domain comes from
studies with the middle T derived from the viral mutant,
dl1015. This mutation is a 10 amino acid deletion in
middle T starting at the last of the three prolines (Mag-
nusson et al. 1981). Studies with this mutant middle T
revealed that the level of associated PI 3-kinase activity
and in vivo levels of PI (3,4,5)P3 and PI (3,4)P2 are re-
duced (Ling et al. 1992). Whether this is also true in the
virus mutation described in this study has not been
addressed. It is not clear if this alteration in the level of
these two PI 3-kinase products is directly due to PI
3-kinase activity or to proteins involved downstream of
this enzyme. It is possible that this proline-rich domain
associates with or regulates the stability of these phos-
phatidylinositol products. Experiments are currently in
progress to identify possible cellular proteins that bind
this proline-rich motif and whether levels of PI (3,4,5)P3
and PI (3,4)P2 are altered.
MATERIALS AND METHODS
Cells and viruses
The wild-type high tumor polyomavirus strain, PTA, has
been previously described (Dawe et al. 1987; Freund et
al. 1987, 1988, 1991). The mutant virus, PTA-Dpro, was
generated by site directed mutagenesis. For mutagene-
sis, the small BamHI/EcoRI fragment of PTA encoding
the middle and small T antigen and the amino-terminal
part of large T as well as the origin of replication was
subcloned into pALTER (Promega). Single stranded
phage was generated, and the mutagenesis reaction
was performed essentially as described by the manufac-
turer (Promega). To generate the deletion of the three
prolines the oligonucleotide, GTACCCCAGCTCATCAT-
CATTCCCAGGGCG, was used. Initially, clones were
screened for appropriate drug resistance and sensitivity,
and then two clones were picked for sequence analysis.
One clone containing the deletion was used to recon-
struct virus. The BamHI/EcoRI fragment containing the
mutation was ligated to the BamHI/EcoRI fragment con-
taining the remainder of the viral genome and the ligation
mix transfected into NIH3T3 cells. NIH3T3 cells, at 25%
confluence, were washed in TBS (30 mM Tris-HCl pH 7.5,
150 mM NaCl) and transfected with approximately 1 mg
of DNA in 500 mg/ml DEAE Dextran for 30 to 45 min at
37°C (Freund et al. 1992a; Sahli et al. 1993). Cells were
washed with TBS and incubated in Dulbecco’s modified
Eagle’s medium (DMEM) plus 10% fetal calf serum. After
1 week or visible cytopathic effect, the cells and media
were harvested and lysates were used for plaque puri-
fication. Virus stocks were then propagated on baby
mouse kidney (BMK) cells (Winocour, 1963; Turler and
Beard, 1985).
BMK cells were prepared and maintained as de-
scribed (Winocour, 1963). Mouse fibroblast NIH3T3 cells
and rat fibroblast F111 cells were routinely grown in
DMEM supplemented with 10% calf serum in a 5% CO2
atmosphere at 37°C.
Cell lines expressing wild-type and mutant middle T
antigens were generated by transfecting F111 cells with
the BamHI/EcoRI fragment of the appropriate viral ge-
nome that had been subcloned into pUC18. This viral
DNA fragment includes the sequences necessary for
transcription and those encoding middle T, small T, and
the amino terminal fragment of large T antigen (Tooze,
1980). These plasmids were cotransfected with pSVneo
(Southern and Berg, 1982) into F111, using the CaPO4
method (Sambrook et al. 1989), and G418 resistant col-
onies were isolated. Several independent clones ex-
pressing wild-type and mutant middle T antigen were
used in this study, including PTA, PTA-Dpro, and PTA-
1387T (Carmichael et al. 1982). As a control, cells trans-
fected with pSVneo alone and resistant to G418 were
used.
FIG. 7. Mammary tumors express mutant middle T antigen. Protein
extracts from tumors induced by wild-type or mutant virus were immu-
noblotted with anti-T antibodies to show expression of the T antigens.
migration of large T (LT), truncated large T (DLT), middle T (MT), and
IgG (IgG) is indicated. Lanes 1 and 2, PTA induced mammary tumors;
lanes 3 and 4, PTA-Dpro induced mammary tumors.
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Immortalization assay
Secondary rat embryo fibroblasts were infected with
virus lysates and at 24 h p.i. the cells were plated at
different cell density in DMEM with 10% calf serum.
Whenever the cells reached confluence, they were sub-
cultured at 1–5 [mult] 104 cells per 100-mm plate. The
criteria used to consider cells immortal were continuous
growth with a generation time of approximately 24 h
(Freund et al.1992a).
Transformation assay
The ability of virus to transform cells was measured by
focus forming assay (Carmichael et al. 1984; Dawe et al.
1987) Briefly, 60-mm dishes containing F111 cells at 25%
confluence were infected with lysates containing high
titers of virus (;106 pfu/ml), as well as dilutions of the
stocks. Approximately 24 h p.i. cells were removed with
trypsin and transferred to four 60-mm plates in DMEM
supplemented with 10% calf serum. Every third day the
medium was changed. After the cells reached conflu-
ence, the medium was changed to DMEM with 2% calf
serum. After 14 days the foci were scored and photo-
graphed.
To determine whether the number of foci were due to
the large T antigen function of integration of viral DNA
into host DNA, cloned viral DNA was transfected into
F111 cells. 60-mm dishes containing F111 cells at 25%
confluence were cotransfected, using the CaPO4 method
(Sambrook et al. 1989), with plasmids containing the
BamHI/EcoRI fragment of the appropriate viral genome
that had been subcloned into pUC18 and pSVneo (South-
ern and Berg, 1982). This viral DNA fragment includes the
sequences necessary for transcription and those encod-
ing middle T antigen, small T antigen and the amino
terminal fragment of large T antigen (Tooze, 1980). Ap-
proximately 24 h after transfection, the cells were trans-
ferred to two 60-mm plates for focus formation and one
100-mm plate for selection of G418 resistant colonies.
The medium was changed every third day on the plates
used for focus formation; initially, DMEM supplemented
with 10% calf serum was used; when the cells reached
confluence, DMEM with 2% calf serum was used. G418
resistant colonies were selected with DMEM with 10%
calf serum containing 400 mg/ml G418. After 3 weeks, the
foci and G418 resistant colonies were scored.
Analysis of viral proteins
Viral gene expression was analyzed from either virus-
infected NIH3T3 cells, cell lines expressing middle T
antigen, or tumors (Dawe et al. 1987; Dahl et al., 1992;
Freund et al. 1992a). NIH3T3 cells grown to 50% conflu-
ence in 100-mm diameter dishes were infected with virus
lysates of approximately 106 pfu/ml and dilutions of the
lysates as indicated. Thirty h p.i. the cells were washed
in phosphate buffered saline (PBS) and lysed in 0.5 ml
NP40 lysis buffer (137 mM NaCl, 20 mM Tris-HCl pH 9, 1
mM MgCl2, 1 mM CaCl2, 10% glycerol, 1% NP40, 0.01
mg/ml aprotinin, 0.005 mg/ml leupeptin, 0.1 mM sodium
orthovanadate, 0.1 mg/ml PMSF). Cells expressing wild-
type or mutant middle T were washed in PBS and lysed
in 1 ml NP40 lysis buffer. Tumors that had been stored at
270° were thawed and homogenized in NP40 lysis
buffer. Lysates were cleared at 13,000 g, and the protein
concentration determined by the Bradford assay. Fifty
micrograms of protein was suspended in SDS sample
buffer, the proteins resolved by SDS-PAGE electrophore-
sis, and electrophoretically transferred to nitrocellulose
membrane (Harlow and Lane, 1988). Immunoblotting
was done by standard procedures (Harlow and Lane,
1988). The membrane was probed with a monoclonal
antibody to polyoma T antigens, F4 (Pallas et al. 1986), or
with rabbit polyclonal antibodies to VP1 and visualized
using the ECL method (Amersham).
Coimmunoprecipitation
Five hundred micrograms of total protein from each
extract was incubated with 5 ml of an anti-middle T
antibody for 2 h. Immune complexes were collected on
protein A-sepharose, washed three times with lysis
buffer, and eluted in SDS sample buffer. The immunopre-
cipitated proteins were immunoblotted by standard pro-
cedures (Harlow and Lane, 1988). To detect MT-shc as-
sociation, Pab762 (Dilworth and Horner, 1993; Dilworth et
al. 1994) was used for the immunoprecipitation, and
anti-shc rabbit antibody (Upstate Biotechnology Inc.) was
used to probe the immunoblot. The MT-PI 3-kinase as-
sociation was detected using F4 (Pallas et al. 1986) for
immunoprecipitation and a mouse monoclonal antibody
against PI-3K (upstate Biotechnology Inc.) for detection
on the immunoblot.
Viral replication
To compare the levels of viral DNA replication of wild-
type and mutant viruses, NIH3T3 cells were infected with
lysates of PTA and PTA-Dpro at ;106 pfu/ml and dilutions
of the PTA stock as indicated. The cells were washed
with PBS and lysed with STE (100 mM NaCl, 10 mM
Tris-HCl pH 7.5, 1 mM EDTA) containing 1% SDS at 0, 4,
16, 24, and 32 h p.i. (Freund et al. 1994). To determine the
level of viral replication during the early phases of infec-
tion in the mouse, newborn C3H mice were inoculated
intraperitoneally with 50 ml of virus lysate and the kid-
neys were excised from 12- and 25-day-old infected mice
and homogenized in STE containing 1% SDS (Dubensky
et al. 1991; Freund et al. 1994).
DNA was purified from the extracts by incubating the
solution with 100 mg/ml proteinase K at 50°C for 1 h,
followed by phenol-chloroform extraction and ethanol
precipitation. The precipitated nucleic acid was redis-
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solved in STE and the RNA digested with 100 mg/ml
RNase, the solution phenol-chloroform extracted and the
DNA ethanol precipitated. To determine the level of viral
DNA, 1 mg of total DNA was digested with EcoRI, sub-
jected to electrophoresis on 1% agarose gel and trans-
ferred to nylon membrane using standard techniques
(Sambrook et al. 1989) and hybridized with cloned viral
DNA labeled with digoxigenin as previously described
(Yi et al. 1997). Viral DNA was detected with anti-digoxi-
genin Fab fragments conjugated to alkaline phosphatase
and visualized with a chemiluminescent substrate
(Boehringer Mannheim).
Viral replication during the early phases of infection in
the mouse was also determined by immunocytochemis-
try. Unstained sections of kidney from 12- and 25-day-old
infected mice were evaluated using the peroxidase an-
tiperoxidase procedure (Dako PAP kit), using a rabbit
anti-polyomavirus VP1 as the primary antibody (Duben-
sky et al. 1991). Positive reaction to the antigen was
indicative of productive lytic infection.
Generation of tumor profiles
C3H/BiDa mice, less than 24 h old, were inoculated
intraperitoneally with 50 ml of virus lysates with titers of
approximately 106 pfu/ml. Approximately 20 mice were
inoculated with both PTA and PTA-Dpro. Mice were nec-
ropsied with moribund or after 6 months. Upon necropsy
all overt tumor were recorded, portions of tumors fixed in
Bouin’s fluid, and confirmed histologically (Dawe et al.
1987).
Verification of viral genotype in tumors
A portion of frozen tumor was thawed, homogenized in
DMEM, frozen, and thawed three times and cleared by
centrifugation. The supernatant was used to infect BMK
cells. After visible cytopathic effect, the supernatant and
cells were collected and made into a crude virus lysate.
Lysate (2 ml) was mixed with 20 ml of GeneReleaser
(BioVentures Inc.), microwaved, mixed with appropriate
primers, CACAAGGGAATGGAATG (nucleotide 900) and
GGTGGAGTGTGCTAGAAATGCCGGG (nucleotide 1500),
and reagents, and amplified by PCR. The resulting 600
nucleotide fragment was cloned and three independent
isolated plasmids were sequenced by the Biopolymer Lab-
oratory at the University of Maryland, Baltimore as previ-
ously described (Bauer et al. 1995; Yi et al. 1997).
ACKNOWLEDGMENTS
This work was supported by Public Health Service grant CA63111
from the National Cancer Institute.
REFERENCES
Auger, K. R., Carpenter, C. L., Shoelson, S. E., Piwnica-Worms, H., and
Cantley, L. C. (1992). Polyomavirus middle T antigen-pp60c-src com-
plex associates with purified phosphatidylinositol 3-kinase in vitro.
J. Biol. Chem. 267, 5408–5417.
Bauer, P. H., Bronson, R. T., Fung, S. C., Freund, R., Stehle, T., Harrison,
S. C., and Benjamin, T. L. (1995). Genetic and structural analysis of a
virulence determinant in polyomavirus VP1. J. Virol. 69, 7925–7931.
Benjamin, T. L. (1982). The hr-t gene of polyoma virus. Biochim. Biophys.
Acta 695, 69–95.
Bolen, J. B., Thiele, C. J., Israel, M. A., Yonemoto, W., Lipsich, L. A., and
Brugge, J. S. (1984). Enhancement of cellular src gene product as-
sociated tyrosyl kinase activity following polyoma virus infection and
transformation. Cell 38, 767–777.
Bronson, R., Dawe, C., Carroll, J., and Benjamin, T. (1997). Tumor
induction by a transformation-defective polyoma virus mutant
blocked in signaling through shc. Proc. Natl. Acad. Sci. USA 94,
7954–7958.
Campbell, K. S., Ogris, E., Burke, B., Su, W., Auger, K. R., Druker, B. J.,
Schaffhausen, B. S., Roberts, T. M., and Pallas, D. C. (1994). Polyoma
middle tumor antigen interacts with SHC protein via the NPTY (asn-
pro-thr-tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA
91, 6344–6348.
Carmichael, G. G., and Benjamin, T. L. (1980). Identification of DNA
sequence changes leading to loss of transforming ability in polyoma
virus. J. Biol. Chem. 255, 230–235.
Carmichael, G. G., Schaffhausen, B. S., Dorsky, D. I., Oliver, D. B., and
Benjamin, T. L. (1982). Carboxy terminus of polyoma middle-sized
tumor antigen is required for attachment to membranes, associated
protein kinase activities, and cell transformation. Proc. Natl. Acad.
Sci. USA 79, 3579–3583.
Carmichael, G. G., Schaffhausen, B. S., Mandel, G., Liang, T. J., and
Benjamin, T. L. (1984). Transformation of polyoma virus is drastically
reduced by substitution of phenylalanine for tyrosine at residue 315
of middle-sized tumor antigen. Proc. Natl. Acad. Sci. USA 81, 679–
683.
Coutneidge, S. A., and Smith, A. E. (1983). Polyoma virus transforming
protein associates with the product of the c-src cellular gene. Nature
303, 435–439.
Cowie, A., Villiers, J. De, and Kamen, R. (1986). Immortalization of rat
embryo fibroblasts by mutant polyomavirus large T antigens deficient
in DNA binding. Mol. Cell. Biol. 6, 4344–4352.
Dahl, J., Freund, R., Blenis, J., and Benjamin, T. L. (1996). Studies of
partially transforming polyomavirus mutants establish a role for
phosphatidylinositol 3-kinase in activation of pp70 S6 kinase. Mol.
Cell. Biol. 16, 2728–2735.
Dahl, J., Thathamangalam, U., Freund, R., and Benjamin, T. L. (1992).
Functional asymmetry of the regions juxtaposed to the membrane-
binding sequence of polyomavirus middle T antigen. Mol. Cell. Biol.
12, 5050–5058.
Dawe, C. J., Freund, R., Mandel, G., Ballmer-Hofer, K., Talmage, D., and
Benjamin, T. L. (1987). Variations in polyoma virus genotype in rela-
tion to tumor induction in mice: Characterization of wild type strains
with widely differing tumor profiles. Am. J. Pathol. 127, 243–261.
Dilworth, S. M., and Horner, V. P. (1993). Novel monoclonal antibodies
that differentiate between the binding of pp60c-src or protein phos-
phatase 2A by polyomavirus middle T antigen. J. Virol. 64, 2235–2244.
Dilworth, S. M., Brewster, C. E., Jones, M. D., Lanfrancone, L., Pelicci, G.,
and Pelicci, P. G. (1994). Transformation of polyoma virus middle
T-antigen involves the binding and tyrosine phosphorylation of Shc.
Nature 367, 87–90.
Druker, B. J., Ling, L. E., Cohen, B., Roberts, T. M., and Schaffhausen,
B. S. (1990). A completely transformation-defective point mutant of
polyomavirus middle T antigen which retains full associated phos-
phatidylinositol kinase activity. J. Virol. 64, 4454–4461.
Dubensky, T. W., and Villarreal, L. P. (1984). The primary site of replica-
tion alters the eventual site of persistent infection by polyoma virus
in mice. J. Virol. 50, 541–546.
Dubensky, T. W., Freund, R., Dawe, C. J., and Benjamin, T. L. (1991).
429TRANSFORMATION PROPERTIES OF POLYOMA MUTANT
Polyomavirus replication in mice: Influences of VP1 and route of
inoculation. J. Virol. 65, 342–349.
Dunn, T. B. (1959). Morphology of memory tumors in mice. In ‘‘The
Physiopathology of Cancer’’ (F. Hamburger, and W. Fishman, Eds.),
pp. 38–84. Heober, New York.
Dyson, N., Bernards, R., Friend, S. H., Goodling, L. R., Hassel, J. A.,
Major, E. O., Pipas, J. M., Van Dyke, T., and Harlow, E. (1990). Large
T antigen of many polyomaviruses are able to form complexes with
the retinoblastoma protein. J. Virol. 64, 1353–1356.
Eckhart, W. (1977). Complementation between temperature-sensitive
and host-range nontransforming mutants of polyoma virus. Virology
77, 589–597.
Eddy, B. E. (1969). Polymer virus. Virol. Monogr. 7, 1–114.
Eddy, B. E., Steward, S. E., and Grubbs, G. E. (1958). Influence of tissue
culture passage, storage, temperature, and drying on viability of SE
polyoma virus. Proc. Soc. Exp. Biol. 99, 289–292.
Francke, B., and Eckhart, W. (1973). Polyoma gene function required for
viral DNA synthesis. Virology 55, 127–135.
Freund, R., Bauer, P. H., Crissman, H. A., Bradbury, E. M., and Benjamin,
T. L. (1994). Host range and cell cycle activation properties of poly-
omavirus large T antigen mutants defective in pRB binding. J. Virol.
68, 7227–7234.
Freund, R., Bronson, R. T., and Benjamin, T. L. (1992a). Separation of
immortalization from tumor induction with polyoma large T mlutants
that fail to bind the retinoblastoma gene product. Oncogene 7, 1979–
1987.
Freund, R., Calderone, A., Dawe, C. J., and Benjamin, T. L. (1991).
Polyomavirus tumor induction in mice: Effects of polymorphisms of
VP1 and large T antigen. J. Virol. 65, 335–341.
Freund, R., Dawe, C. J., and Benjamin, T. L. (1988). A duplication of
non-coding sequences in polyoma virus is required for the develop-
ment of thymic tumors in mice. J. Virol. 62, 3896–3899.
Freund, R., Dawe, C. J., Carroll, J. P., and Benjamin, T. L. (1992b).
Changes in frequency, morphology, and behavior of tumors induced
in mice by a polyoma virus mutant with a specifically altered onco-
gene. Am. J. Pathol. 141, 1409–1425.
Freund, R., Mandel, G., Carmichael, G. G., Barncastle, J., Dawe, C. J.,
and Benjamin, T. L. (1987). Polyomavirus tumor induction in mice:
Influences of viral coding and non-coding sequences on tumor pro-
files. J. Virol. 61, 2232–2239.
Fried, M. (1970). Characterization of a temperature-sensitive mutant of
polyoma virus. Virology 40, 605–617.
Griffin, B. E., Ito, Y., Novak, U., Spurr, N., Dilworth, S., Smolar, N., Plllak,
R., Smith, K., and Rifkin, D. B. (1980). early mutants of polyoma virus
(dl8 and dl23) with altered transformation properties: Is polyoma
virus middle T antigen a transforming gene product? Cold Spring
Harbor Symp. Quant. Biol. 44, 271–282.
Gross, L. (1983). ‘‘Oncogenic Viruses,’’ pp. 737–828. Pergamon Press,
Oxford.
Harlow, E., and Lane, D. (1988). In ‘‘Antibodies: A Laboratory Manual.’’
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Holman, P. S., Gjoerup, O. V., Davin, T., and Schaffhausen, B. S. (1994).
Characterization of an immortalizing N-terminal domain of polyoma-
virus large T antigen. J. Virol. 68, 668–673.
Kaplan, D. R., Whitman, M., Schaffhausen, B. S., Raptis, L., Garcea, R. L.,
Pallas, D. C., Roberts, T. M., and Cantley, L. (1986). Phosphatidylino-
sitol metabolism and polyoma-mediated transformation. Proc. Natl.
Acad. Sci. USA 83, 3624–3628.
Kornbluth, S., Sudol, M., and Hanafusa, H. (1987). Association of the
polyomavirus middle-T antigen with c-yes protein. Nature 325, 171–
173.
Larose, A., Dyson, N., Sullivan, M., Harlow, E., and Bastin, M. (1991).
Polyomavirus large T mutants affected in retinoblastoma protein
binding are defective in immortalization. J. Virol. 65, 2308–2313.
Ling, L. E., Druker, B. J., Cantley, L. E., and Roberts, T. M. (1992).
Transformation-defective mutants of polyomavirus middle T antigen
associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are
unable to maintain wild-type levels of PI 3-kinase products in intact
cells. J. Virol. 66, 1702–1708.
Magnusson, G., Nilsson, M. G., Dilworth, S. M., and Smolar, N. (1981).
Characterization of polyoma mutants with altered middle and large
T-antigens. J. Virol. 39, 673–683.
Markland, W., Oostra, B. A., Harvey, R., Marikham, A. F., Colledge, W. H.,
and Smith, A. E. (1986). Site-directed mutagenesis of polyomavirus
middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.
J. Virol. 59, 384–391.
Markland, W., and Smith, A. E. (1987). Mutants of polyomavirus middle-T
antigen. Biochim. Biophys. Acta 907, 299–321.
Mudrak, I., Ogris, E., Rotheneder, H., and Wintersberger, E. (1994).
Coordinated trans activation of DNA synthesis and precursor pro-
ducing enzymes by polyomavirus large T antigen through interaction
with the retinoblastoma protein. Mol. Cell. Biol. 14, 1886–1892.
Pallas, D. C., Fu, H., Haehnel, L. C., Weller, W., Collier, R. J., and Roberts,
T. M. (1994). Association of polyomavirus middle tumor antigen with
14–3–3 proteins. Science 265, 535–537.
Pallas, D. C., Schley, C., Mahoney, M., Harlow, E., Schaffhausen, B. S.,
and Roberts, T. M. (1986). Polyomavirus small t antigen: Overproduc-
tion in bacteria, purification, and utilization for monoclonal and poly-
clonal antibody production. J. Virol. 60, 1075–1084.
Pallas, D. C., Sharhrik, L. K., Martin, B. L, Jaspers, S., Miller, T. B.,
Brautigan, D. L., and Roberts, T. M. (1990). Polyoma small and middle
T antigens and SV40 small t antigen form stable complexes with
protein phosphatase 2A. Cell 60, 167–176.
Rassoulzadegan, M., Naghashfar, Z., Cowie, A., Grisoni, M., Kamen, R.,
and Cuzin, F. (1983). Expression of the large T antigen of polyoma-
virus promotes the establishment in culture of ‘‘normal’’ rodent fibro-
blast cell lines. Proc. Natl. Acad. Sci. USA 80, 4345–4358.
Ren, R., Mayer, B. J., Cicchetti, P., and Baltimore, D. (1993). Identification
of a ten-amino acid proline-rich SH3 binding site. Science 259,
1157–1161.
Rowe, W. P., Hartley, J. W., Estes, J. D., and Huebner, R. J. (1959). Studies
of mouse polyoma virus infection. I. Procedures for quantitation and
detection of virus. J. Exp. Med. 109, 379–391.
Sahli, R., Freund, R., Dubensky, T., Garcea, R., Bronson, R., and Benjamin,
T. (1993). Defect in entry and altered pathogenicity of a polyoma virus
mutant blocked in VP2 myristylation. Virology 192, 142–153.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). ‘‘Molecular Cloning:
A Laboratory Manual,’’ 2nd ed. Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY.
Schaffhausen, B. S., and Benjamin, T. L. (1979). Phosphorylation of
polyoma T antigens. Cell 18, 935–946.
Schlegel, R., and Benjamin, T. L. (1978). Cellular alterations dependent
upon the polyoma virus hr-t function: Separation of mitogenic from
transforming capacities. Cell 14, 587–599.
Sheng, Q., Denis, D., Ratnofsky, M., Roberts, T. M., DeCaprio, J. A., and
Schaffhausen, B. (1997). The DnaJ domain of polyomavirus large T
antigen is required to regulate Rb family tumor suppressor function.
J. Virol. 71, 9410–9416.
Smolar, N., and Griffin, B. E. (1981). DNA sequences of polyoma virus
early deletion mutants. J. Virol. 38, 95 8–967.
Southern, P. J., and Berg, P. (1982). Transformation of mammalian cells
to antibiotic resistance with a bacterial gene under control of the
SV40 early region promoter. J. Mol. Appl. Genet. 1, 327–332.
Su, W., Liu, W., Schaffhausen, B. S., and Roberts, T. M. (1995). Associ-
ation of polyomavirus middle tumor antigen with phospholipase C-g1.
J. Biol. Chem. 270, 12331–12334.
Talmage, D., Freund, R., Young, A. T., Dahl, J., Dawe, C. J., and Benjamin,
T. L. (1989). Phosphorylation of middle T by pp60c-src.. A switch for
binding of phosphatidylinositol 3-kinase and optimal tumorigenesis.
Cell 59, 55–65.
Talmage, D. A., Freund, R., Dubensky, T., Salcedo, M., Gariglio, P.,
Rangel, L. M., Dawe, C. J., and Benjamin, T. L. (1992). Heterogeneity
in state and expression of viral DNA in polyoma virus-induced tu-
mors of the mouse. Virology 187, 734–747.
430 YI AND FREUND
Tooze, J. (1980). ‘‘DNA tumor viruses.’’ Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY.
Turler, H., and Beard, P. (1985). ‘‘Virology: A Practical Approach,’’ (B. W. J.
Mahy, Ed.), pp. 169–192. IRL Press, Oxford.
Walter, G., Ruediger, R., Slaughter, C., and Mumby, M. (1990). Associa-
tion of protein phosphatase 2A with polyoma virus medium tumor
antigen. Proc. Natl. Acad. Sci. USA 87, 2521–2525.
Whitman, M., Kaplan, D. R., Schaffhausen, B. S., Cantley, L., and Rob-
erts, T. M. (1985). Association of phosphatidylinositol kinase activity
with polyoma middle T competent for transformation. Nature 315,
239–242.
Winocour, E. (1963). Purification of polyoma virus. Virology 19, 158–168.
Yi, X., Peterson, J., and Freund, R. (1997). Transformation and tumori-
genic properties of a mutant polyomavirus containing a middle T
antigen defective in shc binding. J. Virol. 71, 6279–6286.
Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., and Schreiber,
S. L. (1994). Structural basis for the binding of proline-rich peptides to
SH3 domains. Cell 76, 933–945.
431TRANSFORMATION PROPERTIES OF POLYOMA MUTANT
